Skip to content

QuidelOrtho Corporation QDEL Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Abbott logo
AbbottABT
Danaher logo
DanaherDHR
Revvity logo
RevvityRVTY
Agilent Technologies logo
Agilent TechnologiesA
Labcorp Holdings logo
Labcorp HoldingsLH
Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's common stock, shares authorized (in shares)?
QuidelOrtho Corporation (QDEL) reported common stock, shares authorized (in shares) of $126.2M in Q1 2026.
How has QuidelOrtho Corporation's common stock, shares authorized (in shares) changed year-over-year?
QuidelOrtho Corporation's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $126.2M to $126.2M.
What is the long-term trend for QuidelOrtho Corporation's common stock, shares authorized (in shares)?
Over 2 years (2023 to 2025), QuidelOrtho Corporation's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $126.2M to $126.2M.